Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial-Reference-Cited by-同舟云学术

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial

Published:2002-03 Issue:9308 Volume:359 Page:733-740
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals;Harindra;Lancet,1997

2. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA Panel;Carpenter;JAMA,1997

3. Guidelines for the use of antiretroviral agents in pediatric HIV infection;MMWR Morb Mortal Wkly Rep,1998

4. Current evidence for the use of paediatric antiretroviral therapy—a PENTA analysis;Sharland;Eur J Paediatr,2000

5. Treatment of human immunodeficiency virus 1 -infected children with the protease inhibitor nelfinavir mesylate;Krogstad;Clin Infect Dis,1999

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Vitamin D Supplementation on CD4 Count in HIV-Infected Children and Adolescents in North India: A Non-Randomized Comparative Study;Journal of Tropical Pediatrics;2022-08-04

2. Immunologic Response of HIV-Infected Children to Different Regimens of Antiretroviral Therapy: A Retrospective Observational Study;AIDS Research and Treatment;2020-08-13

3. Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study;BMC Pediatrics;2020-03-03

4. Association of Antiretroviral Drug Regimen With Viral Suppression in HIV-positive Children on Antiretroviral Therapy in Eswatini;Pediatric Infectious Disease Journal;2019-08

5. Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy;Pediatric Infectious Disease Journal;2017-05